Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: Modulated by G proteins, kinases, and myosin phosphatase

Physiological Reviews

Volumn 83, Issue 4, 2003, Pages 1325-1358

  Somlyo, Andrew P ^a   Somlyo, Avril V ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CALCIUM ION; CPI 17; CYCLIC GMP DEPENDENT PROTEIN KINASE; FOCAL ADHESION KINASE; GUANINE NUCLEOTIDE BINDING PROTEIN; LIM PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MYOSIN ADENOSINE TRIPHOSPHATASE; MYOSIN LIGHT CHAIN KINASE; MYOSIN LIGHT CHAIN PHOSPHATASE; MYOSIN PHOSPHATASE; PHOSPHATASE; PROTEIN KINASE C INHIBITOR; PROTEIN P21; PROTEIN TYROSINE KINASE; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ASTHMA; CALCIUM TRANSPORT; CANCER; CANCER GROWTH; CELL MEMBRANE; DEPHOSPHORYLATION; ENZYME ACTIVITY; HUMAN; HYPERTENSION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE;

EID: 0141751697     PISSN: 00319333     EISSN: None     Source Type: Journal    
DOI: 10.1152/physrev.00023.2003     Document Type: Review

References (442)

1. Abdel-Latif AA. Cross talk between cyclic nucleotides and polyphosphoinositide hydrolysis, protein kinases, and contraction in smooth muscle. Exp Biol Med 226: 153-163, 2001.
2. Adam LP, Franklin MT, Raff GJ, and Hathaway DR. Activation of nitrogen-activated protein kinase in porcine carotid arteries. Circ Res 76: 183-190, 1995.
3. Adelstein RS and Klee CB. Purification and characterization of smooth muscle myosin light chain kinase. J Biol Chem 256: 7501-7509, 1981.
4. Aepfelbacher M, Trasak C, Wilharm G, Wiedemann A, Trulzsch K, Krauss K, Gierschik P, and Heesemann J. Characterization of YpoT effects on Rho GTPases in Yersinia enterocolitica infected cells. J Biol Chem. In press.
5. Alblas J, Ulfman L, Hordijk P, and Koenderman L. Activation of Rhoa and ROCK are essential for detachment of migrating leukocytes. Mol Biol Cell 12: 2137-2145, 2001.
6. Alessi D, MacDougall LK, Sola MM, Ikebe M, and Cohen P. The control of protein phosphatase-1 by targetting subunits. The major myosin phosphatase in avian smooth muscle is a novel form of protein phosphatase-1. Eur J Biochem 210: 1023-1035, 1992.
7. 2+, and junctions in endothelial hyperpemeability. Circ Res 87: 268-271, 2000.
8. + channels as a new mechanism of agonist-induced vasoconstruction. Proc Natl Acad Sci USA 99: 14560-14565, 2002.
9. Altmann C, Steenpaß V, Czyborra P, Hein P, and Michel MC. Comparison of signalling mechanisms involved in rat mesenteric microvessel contraction by noradrenaline and sphingosylphosphorylcholine. Br J Pharmacol 138: 261-271, 2003.
10. Amano M, Fukata Y, and Kaibuchi K. Regulation and fuctions of Rho-associated kinase. Exp Cell Res 261: 44-51, 2000.
11. Amano T, Tanabe K, Eto T, Narumiya S, and Mizuno K. LIM-kinase 2 induces formation of stress fibres, focal adhesions and membrane blebs, dependent on its activation by Rho-associated kinase-catalysed phosphorylation at threonine-505. Biochem J 354: 149-159, 2001.
12. 2+ sensitization of the contractile element in chicken gizzard smooth muscle. Pflügers Arch 441: 189-199, 2000.
13. Andrea JE and Walsh MP. Protein kinase C of smooth muscle. Hypertension 20: 585-595, 1992.
14. 2+ sensitization of smooth muscle contraction through activation of Rho-kinase. Pflügers Arch 441: 596-603, 2001.
15. Aullo P, Giry M, Olsnes S, Popoff MR, Kocks C, and Boquet P. A chimeric toxin to study the role of the 21 kDa GTP binding protein rho in the control of actin microfilament assembly. EMBO J 12: 921-931, 1993.
16. Aurandt J, Vikis HG, Gutkind JS, Ahn N, and Guan KL. The semaphorin receptor plexin-B1 signals through a direct interaction with the Rho-specific nucleotide exchange factor, LARG. Proc Natl Acad Sci USA 99: 12085-12090, 2002.
17. Bach I. The LIM domain: regulation by association. Mech Dev 9: 5-17, 2000.
18. Bagrodia S and Cerione RA. Pak to the future. Trends Cell Biol 9: 350-355, 1999.
19. Bao J, Oishi K, Yamada T, Liu L, Nakamura A, Uchida MK, and Kohama K. Role of the short isoform of myosin light chain kinase in the contraction of cultured smooth muscle cells as examined by its down-regulation. Proc Natl Acad Sci USA 99: 9556-9561, 2002.
20. Batchelor TJ, Sadaba JR, Ishola A, Pacaud P, Munsch CM, and Beech DJ. Rho-kinase inhibitors prevent agonist-induced vasospasm in human internal mammary artery. Br J Pharmacol 132: 302-308, 2001.
21. Bayless KJ and Davis GE. The Cdc42 and rac1 GTPases are required for capillary lumen formation in three-dimensional extra-cellular matrices. J Cell Sci 115: 1123-1136, 2002.
22. Begum N, Sandu OA, and Duddy N. Negative regulation of rho signaling by insulin and its impact on actin cytoskeleton organization in vascular smooth muscle cells: role of nitric oxide and cyclic guanosine monophosphate signaling pathways. Diabetes 51: 2256-2263, 2002.
23. Benais-Pont G, Punn A, Flores-Maldonado C, Eckert J, Raposo G, Fleming TP, Cereijido M, Balda MS, and Matter K. Identification of a tight-junction-associated guanine nucleotide exchange factor that activates Rho and regulates paracellular permeability. J Cell Biol 160: 729-740, 2003.
24. Bence K, Ma W, Kozasa T, and Huang XY. Direct stimulation of Bruton's tyrosine kinase by G(q)-protein alpha-subunit. Nature 389: 296-299, 1997.
25. 13-dependent plasma membrane recruitment of p115RhoGEF. Biochem J 371: 709-720, 2003.
26. Birukov KG, Csortos C, Marzilli L, Dudek S, Ma SF, Bresnick AR, Verin AD, Cotter RJ, and Garcia JG. Differential regulation of alternatively spliced endothelial cell myosin light chain kinase isoforms by p60(Src). J Biol Chem 276: 8567-8573, 2001.
27. Birukov KG, Schavocky JP, Shirinsky VP, Chibalina MV, Van Eldik LJ, and Watterson DM. Organization of the genetic locus for chicken myosin light chain kinase is complex: multiple proteins are encoded and exihibit differential expression and localization. J Cell Biochem 70: 402-413, 1998.
28. Bishop AL and Hall A. Rho GTPases and their effector proteins. Biochem J 348: 241-255, 2000.
29. Blue EK, Goeckeler ZM, Jin Y, Hou L, Dixon SA, Herring BP, Wysolmerski RB, and Gallagher PJ. 220- and 130-kDa MLCKs have distinct tissue distributions and intracellular localization patterns. Am J Physiol Cell Physiol 282: C451-C460, 2002.
30. Bodie SL, Ford I, Greaves M, and Nixon GF. Thrombin-induced activation of RhoA in platelet shape change. Biochem Biophys Res Commun 287: 71-76, 2001.
31. Boettner B and Van Aelst L. The role of Rho GTPases in disease development. Gene 286: 155-174, 2002.
32. Bolton TB, Gordienko DV, Pueovsky V, Parsons S, and Povstyan O. Calcium release events in excitation-contraction coupling in smooth muscle. In: Role of the Sarcoplasmic Reticulum in Smooth Muscle, edited by Goode DJC. West Sussex, UK: Wiley, 2002, p. 154-173.
33. 2+ via a rho- and rho kinase-dependent mechanism. Circulation 102: 2402-2410, 2000.
34. Bolz SS, Vogel L, Sollinger D, Derwand R, de Wit C, Loirand G, and Pohl U. Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the RhoA/Rho kinase pathway. Circulation 107: 3081-3087, 2003.
35. Booden MA, Siderovski DP, and Der CJ. Leukemia-associated Rho guanine nucleotide exchange factor promotes Gαq-coupled activation of RhoA. Mol Cell Biol 22: 4053-4061, 2002.
36. Boquet P. Bacterial toxins inhibiting or activating small GTP-binding proteins. Ann NY Acad Sci 886: 83-90, 1999.
37. Boquet P. The cytotoxic necrotizing factor 1 (CNF1) from Escherichia coli. Toxicon 39: 1673-1680, 2001.
38. 2+ sensitization via myosin phosphatase inhibition. J Biol Chem 277: 23441-23446, 2002.
39. Bradley AB and Morgan KG. Alterations in cytoplasmic calcium sensitivity during porcine coronary artery contractions as detected by aequorin. J Physiol 385: 437-448, 1987.
40. Bresnick AR. Molecular mechanisms of nonmuscle myosin-II regulation. Curr Opin Cell Biol 11: 26-33, 1999.
41. Bresnick AR, Wolff-Long VL, Baumann O, and Pollard TD. Phosphorylation on threonine-18 of the regulatory light chain dissociates the ATPase and motor properties of smooth muscle myosin II. Biochemistry 34: 12576-12583, 1995.
42. Brozovich FV. Myosin light chain phosphatase: it gets around. Circ Res 90: 500-502, 2002.
43. Burridge K and Chrzanowska-Wodnicka M. Focal adhesions, contractility, and signaling. Annu Rev Cell Dev Biol 12: 463-519, 1996.
44. Busch C and Aktories K. Microbial toxins and the glycosylation of rho family GTPases. Curr Opin Struct Biol 10: 528-535, 2000.
45. Bustelo XR. Regulatory and signaling properties of the Vav family. Mol Cell Biol 20: 1461-1477, 2000.
46. Carbajal JM and Schaeffer RC Jr. RhoA inactivation enhances endothelial barrier function. Am J Physiol Cell Physiol 277: C955-C964, 1999.
47. 2+ sensitization of rabbit myometrium during pregnancy: role of Rnd3. J Physiol. In press.
48. Carr AN, Sutliff RL, Weber CS, Allen PB, Greengard P, de Lanerolle P, Kranias EG, and Paul RJ. Is myosin phosphatase regulated in vivo by inhibitor-1? Evidence from inhibitor-1 knockout mice. J Physiol 534: 357-366, 2001.
49. Carter RW, Begaye M, and Kanagy NL. Acute and chronic NOS inhibition enhances alpha(2)-adrenoreceptor-stimulated RhoA and Rho kinase in rat aorta. Am J Physiol Heart Circ Physiol 283: H1361-H1369, 2002.
50. Carvajal JA, Germain AM, Ruidobro-Toro JP, and Weiner CP. Molecular mechanism of cGMP-mediated smooth muscle relaxation. J Cell Physiol 184: 409-420, 2000.
51. Casey PJ. Lipid modifications of G proteins. Curr Opin Cell Biol 6: 219-225, 1994.
52. Casey PJ. Protein lipidation in cell signaling. Science 268: 221-225, 1995.
53. Chandra M, Dong WJ, Pan BS, Cheung HC, and Solaro RJ. Effects of protein kinase A phosphorylation on signaling between cardiac troponin I and the N-terminal domain of cardiac troponin C. Biochemistry 36: 13305-13311, 1997.
54. Chang L and Karin M. Mammalian MAP kinase signalling cascades. Nature 410: 37-40, 2001.
55. Chen XQ, Tan I, Ng CH, Hall C, Lim L, and Leung T. Characterization of RhoA-binding kinase ROKalpha implication of the pleckstrin homology domain in ROKalpha function using region-specific antibodies. J Biol Chem 277: 12680-12688, 2002.
56. Chen Z, Wells CD, Sternweis PC, and Sprang SR. Structure of the rgRGS domain of p115RhoGEF. Nat Struct Biol 8: 805-809, 2001.
57. Chew TL, Masaracchia RA, Goeckeler ZM, and Wysolmerski RB. Phosphorylation of nonmuscle myosin II regulatory light chain by p21-activated kinase (gamma-PAK). J Muscle Res Cell Motil 19: 839-854, 1998.
58. Chew TL, Wolf WA, Gallagher PJ, Matsumura F, and Chisholm RL. A fluorescent resonant energy transfer-based biosensor reveals transient and regional myosin light chain kinase activation in lamella and cleavage furrows. J Cell Biol 156: 543-553, 2002.
59. 2+ sensitization of bronchial smooth muscle contraction in antigen-induced airway hyperresponsive rats. Br J Pharmacol 127: 597-600, 1999.
60. Chikumi H, Fukuhara S, and Gutkind JS. Regulation of G protein-linked guanine nucleotide exchange factors for Rho, PDZ-RhoGEF, and LARG by tyrosine phosphorylation. J Biol Chem 277: 12468-12473, 2002.
61. Chikumi H, Vazquez-Prado J, Servitja JM, Miyazaki H, and Gutkind JS. Potent activation of RhoA by Galpha q and Gq-coupled receptors. J Biol Chem 277: 27130-27134, 2002.
62. Chitaley K, Bivalacqua TJ, Champion HC, Usta MF, Hellstrom WJ, Mills TM, and Webb RC. Adeno-associated viral gene transfer of dominant negative RhoA enhances erectile function in rats. Biochem Biophys Res Commun 298: 427-432, 2002.
63. Chitaley K and Webb RC. Microtubule depolymerization facilitates contraction of rat aorta via activation of Rho-kinase. Vasc Pharmacol 38: 157-161, 2002.
64. Chitaley K and Webb RC. Nitric oxide induces dilation of rat aorta via inhibition of rho-kinase signaling. Hypertension 39: 438-442, 2002.
65. Chitaley K, Wingard CJ, Clinton Webb R, Branam H, Stopper VS, Lewis RW, and Mills TM. Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway. Nat Med 7: 119-122, 2001.
66. Chrissobolis S and Sobey CG. Evidence that Rho-kinase activity contributes to cerebral vascular tone in vivo and is enhanced during chronic hypertension. Comparison with protein kinase C. Circ Res 88: 774-779, 2001.
67. Cichowski K, Brugge JS, and Brass LF. Thrombin receptor activation and integrin engagement stimulate tyrosine phosphorylation of the proto-oncogene product, p95vav, in platelets. J Biol Chem 271: 7544-7550, 1996.
68. Cohen P. The origins of protein phosphorylation. Nat Cell Biol 4: E127-E130, 2002.
69. Cohen PT. Protein phosphatase 1-targeted in many directions. J Cell Sci 115: 241-256, 2002.
70. i. Am J Physiol Heart Circ Physiol 262: H754-H762, 1992.
71. Conti MA and Adelstein RS. The relationship between calmodulin binding and phosphorylation of smooth muscle myosin kinase by the catalytic subunit of 3′:5′ cAMP-dependent protein kinase. J Biol Chem 256: 3178-3181, 1981.
72. Cook AK, Carty M, Singer CA, Yamboliev IA, and Gerthoffer WT. Coupling of M(2) muscarinic receptors to ERK MAP kinases and caldesmon phosphorylation in colonic smooth muscle. Am J Physiol Gastrointest Liver Physiol 278: G429-G437, 2000.
73. Coussens LM and Werb Z. Inflammation and cancer. Nature 420: 860-867, 2002.
74. Crichton CA, Templeton AG, McGrath JC, and Smith GL. Thromboxane A2 analogue, U-46619, potentiates calcium-activated force in human umbilical artery. Am J Physiol Heart Circ Physiol 264: H1878-H1883, 1993.
75. Damron DS, Kanaya N, Homma Y, Kim SO, and Murray PA. Role of PKC, tyrosine kinases, and Rho kinase in alpha-adrenoreceptor-mediated PASM contraction. Am J Physiol Lung Cell Mol Physiol 283: L1051-L1064, 2002.
76. Dechert MA, Holder JM, and Gerthoffer WT. p21-activated kinase 1 participates in tracheal smooth muscle cell migration by signaling to p38 MAPK. Am J Physiol Cell Physiol 281: C123-C132, 2001.
77. De Lanerolle P, Nishikawa M, Yost DA, and Adelstein RS. Increased phosphorylation of myosin light chain kinase after an increase in cyclic AMP in intact smooth muscle. Science 223: 1415-1417, 1984.
78. Del Pozo MA, Kiosses WB, Alderson NB, Meller N, Hahn KM, and Schwartz MA. Integrins regulate GTP-Rac localized effector interactions through dissociation of Rho-GDI. Nat Cell Biol 4: 232-239, 2002.
79. Deng JT, Sutherland C, Brautigan DL, Eto M, and Walsh MP. Phosphorylation of the myosin phosphatase inhibitors, CPI-17 and PHI-1, by integrin-linked kinase. Biochem J 367: 517-524, 2002.
80. 2+-independent smooth muscle contraction. A novel function for integrin-linked kinase. J Biol Chem 276: 16365-16373, 2001.
81. Denoyelle C, Albanese P, Uzan G, Hong L, Vannier JP, Soria J, and Soria C. Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells. Cell Signal 15: 327-338, 2003.
82. Dirksen WP, Vladic F, and Fisher SA. A myosin phosphatase targeting subunit isoform transition defines a smooth muscle developmental phenotypic switch. Am J Physiol Cell Physiol 278: C589-C600, 2000.
83. Di Salvo J, Nelson SR, and Kaplan N. Protein tyrosine phosphorylation in smooth muscle: a potential coupling mechanism between receptor activation and intracellular calcium. Proc Soc Exp Biol Med 214: 285-301, 1997.
84. Di Salvo J, Steusloff A, Semenchuk L, Satoh S, Kolquist K, and Pfitzer G. Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle. Biochem Biophys Res Commun 190: 968-974, 1993.
85. Dong JM, Leung T, Manser E, and Lim L. cAMP-induced morphological changes are counteracted by the activated RhoA small GTPase and the Rho kinase ROKalpha. J Biol Chem 273: 22554-22562, 1998.
86. Driessens MH, Olivo C, Nagata K, Inagaki M, and Collard JG. B plexins activate Rho through PDZ-RhoGEF. FEBS Lett 529: 168-172, 2002.
87. Ebashi S, Ebashi F, and Kodama A. Troponin as the C ++ receptive protein in the contractile system. J Biochem 62: 137-138, 1967.
88. Edelman AM and Krebs EG. Phosphorylation of skeletal muscle myosin light chain kinase by the catalytic subunit of cAMP-dependent protein kinase. FEBS Lett 138: 293-298, 1982.
89. Essler M, Amano M, Kruse HJ, Kaibuchi K, Weber PC, and Aepfelbacher M. Thrombin inactivates myosin light chain phosphatase via Rho and its target Rho kinase in human endothelial cells. J Biol Chem 273: 2187-21874, 1998.
90. Essler M, Retzer M, Bauer M, Heemskerk JW, Aepfelbacher M, and Siess W. Mildly oxidized low density lipoprotein induces contraction of human endothelial cells through activation of Rho/Rho kinase and inhibition of myosin light chain phosphatase. J Biol Chem 274: 30361-30364, 1999.
91. Essler M, Staddon JM, Weber PC, and Aepfelbacher M. Cyclic AMP blocks bacterial lipopolysaccharide-induced myosin light chain phosphorylation in endothelial cells through inhibition of Rho/Rho kinase signaling. J Immunol 164: 6543-6549, 2000.
92. Eto M, Karginov A, and Brautigan DL. A novel phosphoprotein inhibitor of protein type-1 phosphatase holoenzymes. Biochemistry 38: 16952-16957, 1999.
93. Eto M, Kitazawa T, Yazawa M, Mukai H, Ono Y, and Brautigan DL. Histamine-induced vasoconstriction involves phosphorylation of a specific inhibitor protein for myosin phosphatase by protein kinase C alpha and delta isoforms. J Biol Chem 276: 29072-29078, 2001.
94. Eto M, Ohmori T, Suzuki M, Furuya K, and Morita F. A novel protein phosphatase-1 inhibitory protein potentiated by protein kinase C. Isolation from porcine aorta media and characterization. J Biochem 118: 1104-1107, 1995.
95. Eto M, Senba S, Morita F, and Yazawa M. Molecular cloning of a novel phosphorylation-dependent inhibitory protein of protein phosphatase-1 (CP117) in smooth muscle: its specific localization in smooth muscle. FEBS Lett 410: 356-360, 1997.
96. Eto M, Wong L, Yazawa M, and Brautigan DL. Inhibition of myosin/moesin phosphatase by expression of the phosphoinhibitor protein CPI-17 alters microfilament organization and retards cell spreading. Cell Motil Cytoskeleton 46: 222-234, 2000.
97. Etter EF, Eto M, Wardle RL, Brautigan DL, and Murphy RA. Activation of myosin light chain phosphatase in intact arterial smooth muscle during nitric oxide-induced relaxation. J Biol Chem 276: 34681-34685, 2001.
98. Faure J and Dagher MC. Interactions between Rho GTPases and Rho GDP dissociation inhibitor (Rho-GDI). Biochimie 83: 409-414, 2001.
99. Feil R, Gappa N, Rutz M, Schlossmann J, Rose CR, Konnerth A, Brummer S, Kuhbandner S, and Hofmann F. Functional reconstitution of vascular smooth muscle cells with cGMP-dependent protein kinase I isoforms. Circ Res 90: 1080-1086, 2002.
100. Feng J, Ito M, Ichikawa K, Isaka N, Nishikawa M, Hartshorne DJ, and Nakano T. Inhibitory phosphorylation site for Rho-associated kinase on smooth muscle myosin phosphatase. J Biol Chem 274: 37385-37390, 1999.
101. Feng J, Ito M, Kureishi Y, Ichikawa K, Amano M, Isaka N, Okawa K, Iwamatsu A, Kaibuchi K, Hartshorne DJ, and Nakano T. Rho-associated kinase of chicken gizzard smooth muscle. J Biol Chem 274: 3744-3752, 1999.
102. Folkman J, Hahnfeldt P, and Hlatky L. Cancer: looking outside the genome. Nat Rev Mol Cell Biol. 1: 76-79, 2000.
103. Francis SH and Corbin JD. Structure and function of cyclic nucleotide-dependent protein kinases. Annu Rev Physiol 56: 237-272, 1994.
104. Franklin MT, Wang CL, and Adam LP. Stretch-dependent activation and desensitization of mitogen-activated protein kinase in carotid arteries. Am J Physiol Cell Physiol 273: C1819-C1827, 1997.
105. Friedl P and Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3: 362-374, 2003.
106. 2+-sensitization of smooth muscle. FEBS Lett 440: 183-187, 1998.
107. Fujihara H, Walker LA, Gong MC, Lemichez E, Boquet P, Somlyo AV, and Somlyo AP. Inhibition of RhoA translocation and calcium sensitization by in vivo ADP-ribosylation with the chimeric toxin DC3B. Mol Biol Cell 8: 2437-2447, 1997.
108. Fujioka M, Takahashi N, Odai H, Araki S, Ichikawa K, Feng J, Nakamura M, Kaibuchi K, Hartshorne DJ, Nakano T, and Ito M. A new isoform of human myosin phosphatase targeting/regulatory subunit (MYPT2): cDNA cloning, tissue expression, and chromosomal mapping. Genomics 49: 59-68, 1998.
109. Fukuhara S, Chikumi H, and Gutkind JS. RGS-containing Rho-GEFs: the missing link between transforming G proteins and Rho? Oncogene 20: 1661-1668, 2001.
110. Fukuhara S, Murga C, Zohar M, Igishi T, and Gutkind JS. A novel PDZ domain containing guanine nucleotide exchange factor links heterotrimeric G proteins to Rho. J Biol Chem 274: 5868-5879, 1999.
111. 2+ sensitization of rabbit smooth muscle. J Physiol 500: 95-109, 1997.
112. Gailly P, Wu X, Haystead TA, Somlyo AP, Cohen PT, Cohen P, and Somlyo AV. Regions of the 110-kDa regulatory subunit M110 required for regulation of myosin-light-chain-phosphatase activity in smooth muscle. Eur J Biochem 239: 326-332, 1996.
113. Gale NW, Baluk P, Pan L, Kwan M, Holash J, DeChiara TM, McDonald DM, and Yancopoulos GD. Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth muscle cells. Dev Biol 230: 151-160, 2001.
114. Gallagher PJ, Herring BP, Griffin SA, and Stull JT. Molecular characterization of a mammalian smooth muscle myosin light chain kinase. J Biol Chem 266: 23936-23944, 1991.
115. Gallagher PJ, Herring BP, and Stull JT. Myosin light chain kinases. J Muscle Res Cell Motil 18: 1-16, 1997.
116. Garcia JG, Verin AD, Schaphorst K, Siddiqui R, Patterson CE, Csortos C, and Natarajan V. Regulation of endothelial cell myosin light chain kinase by Rho, cortactin, and p60(src). Am J Physiol Lung Cell Mol Physiol 276: L989-L998, 1999.
117. Genth HJ, Gerhard R, Maeda A, Amano M, Kaibuchi K, Aktories K, and Just I. Entrapment of Rho ADP-ribosylated by Clostridium botulinum C3 exoenzyme in the Rho-GDI-1 complex. J Biol Chem. In press.
118. Gerthoffer WT and Gunst SJ. Invited review: focal adhesion and small heat shock proteins in the regulation of actin remodeling and contractility in smooth muscle. J Appl Physiol 91: 963-972, 2001.
119. Gerthoffer WT, Yamboliev IA, Pohl J, Haynes R, Dang S, and McHugh J. Activation of MAP kinases in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 272: L244-L252, 1997.
120. Gilbert-McClain LI, Verin AD, Shi S, Irwin RP, and Garcia JG. Regulation of endothelial cell myosin light chain phosphorylation and permeability by vanadate. J Cell Biochem 70: 141-155, 1998.
121. Glaven JA, Whitehead I, Bagrodia S, Kay R, and Cerione RA. The Dbl-related protein, Lfc, localizes to microtubules and medi ates the activation of Rac signaling pathways in cells. J Biol Chem 274: 2279-2285, 1999.
122. Goeckeler ZM, Masaracchia RA, Zeng Q, Chew TL, Gallagher P, and Wysolmerski RB. Phosphorylation of myosin light chain kinase by p21-activated kinase PAK2. J Biol Chem 275: 18366-18374, 2000.
123. Gohla A, Schultz G, and Offermanns S. Role for G(12)/G(13) in agonist-induced vascular smooth muscle cell contraction. Circ Res 87: 221-227, 2000.
124. Gong MC, Cohen P, Kitazawa T, Ikebe M, Masuo M, Somlyo AP, and Somlyo AV. Myosin light chain phosphatase activities and the effects of phosphatase inhibitors in tonic and phasic smooth muscle. J Biol Chem 267: 14662-14668, 1992.
125. Gong MC, Fuglsang A, Alessi D, Kobayashi S, Cohen P, Somlyo AV, and Somlyo AP. Arachidonic acid inhibits myosin light chain phosphatase and sensitizes smooth muscle to calcium. J Biol Chem 267: 21492-21498, 1992.
126. 2+ sensitization of smooth muscle. J Biol Chem 272: 10704-10709, 1997.
127. 2+ sensitization in smooth muscle. Mol Biol Cell 8: 279-286, 1997.
128. 2+ sensitization of smooth muscle myosin II. Am J Physiol Cell Physiol 281: C257-C269, 2001.
129. 2+ sensitization of smooth muscle. Proc Natl Acad Sci USA 93: 1340-1345, 1996.
130. Gong MC, Kinter MT, Somlyo AV, and Somlyo AP. Arachidonic acid and diacylglycerol release associated with inhibition of myosin light chain dephosphorylation in rabbit smooth muscle. J Physiol 486: 113-122, 1995.
131. Gorenne I, Nakamoto RK, Phelps C, Beckerle MC, Somlyo AV, and Somlyo AP. LPP, a LIM protein highly expressed in smooth muscle. Am J Physiol Cell Physiol 285: C674-C685, 2003.
132. Gorenne I, Su X, and Moreland RS. Inhibition of p42 and p44 MAP kinase does not alter smooth muscle contraction in swine carotid artery. Am J Physiol Heart Circ Physiol 275: H131-H138, 1998.
133. Gratacap MP, Payrastre B, Nieswandt B, and Offermanns S. Differential regulation of Rho and Rac through heterotrimeric G-proteins and cyclic nucleotides. J Biol Chem 276: 47906-47913, 2001.
134. Greenberg DL, Mize GJ, and Takayama TK. Protease-activated receptor mediated RhoA signaling and cytoskeletal reorganization in LNCaP cells. Biochemistry 42: 702-709, 2003.
135. Gudi T, Chen JC, Casteel DE, Seasholtz TM, Boss GR, and Pilz RB. cGMP-dependent protein kinase inhibits serum-response element-dependent transcription by inhibiting rho activation and functions. J Biol Chem 277: 37382-37393, 2002.
136. 2+ sensitization of contraction in vascular smooth muscle. J Biol Chem 278: 1856-1863, 2003.
137. Hall A and Nobes CD. Rho GTPases: molecular switches that control the organization and dynamics of the actin cytoskeleton. Philos Trans R Soc Lond B Biol Sci 355: 965-970, 2000.
138. Hamaguchi T, Ito M, Feng J, Seko T, Koyama M, Machida H, Takase K, Amano M, Kaibuchi K, Hartshorne DJ, and Nakano T. Phosphorylation of CPI-17, an inhibitor of myosin phosphatase, by protein kinase N. Biochem Biophys Res Commun 274: 825-830, 2000.
139. Hart MJ, Jiang X, Kozasa T, Roscoe W, Singer WD, Gilman AG, Sternweis PC, and Bollag G. Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEF by Galpha13. Science 280: 2112-2114, 1998.
140. Hartshorne DJ, Ito M, and Erdodi F. Myosin light chain phosphatase: subunit composition, interactions and regulation. J Muscle Res Cell Motil 19: 325-341, 1998.
141. Haskell MD, Nickles AL, Agati JM, Su L, Dukes BD, and Parsons SJ. Phosphorylation of p190 on Tyr1105 by c-Src is necessary but not sufficient for EGF-induced actin disassembly in C3H10T1/2 fibroblasts. J Cell Sci 114: 1699-1708, 2001.
142. Haystead CM, Gailly P, Somlyo AP, Somlyo AV, and Haystead TA. Molecular cloning and functional expression of a recombinant 72.5 kDa fragment of the 110 kDa regulatory subunit of smooth muscle protein phosphatase 1M. FEBS Lett 377: 123-127, 1995.
143. Heilbrunn LV and Wiercinski FJ. The action of various cations on muscle protoplasm. J Cell Comp Physiol 29: 15-32, 1947.
144. 2+/force relationship during the contraction-relaxation cycle in the guinea pig ileum. Pflüger Arch 416: 28-35, 1990.
145. 2+ sensitivity in rabbit pulmonary artery smooth muscle. Pfügers Arch 417: 21-28, 1990.
146. 2+ sensitivities of guinea-pig ileum and rabbit pulmonary artery smooth muscle. J Physiol 413: 489-503, 1989.
147. Himpens B and Somlyo AP. Free-calcium and force transients during depolarization and pharmacomechanical coupling in guinea-pig smooth muscle. J Physiol 395: 507-530, 1988.
148. Hirata K, Kikuchi A, Sasaki T, Kuroda S, Kaibuchi K, Matsuura Y, Seki H, Saida K, and Takai Y. Involvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction, J Biol Chem 267: 8719-8722, 1992.
149. Hirotani M, Ohoka Y, Yamamoto T, Nirasawa H, Furuyama T, Kogo M, Matsuya T, and Inagaki S. Interaction of plexin-B1 with PDZ domain-containing Rho guanine nucleotide exchange factors. Biochem Biophys Res Commun 297: 32-37, 2002.
150. Hoffman GR and Cerione RA. Signaling to the Rho GTPases: networking with the DH domain. FEBS Lett 513: 85-91, 2002.
151. Hoffman GR, Nassar N, Oswald RE, and Cerione RA. Fluoride activation of the Rho family GTP-binding protein Cdc42Hs. J Biol Chem 273: 4392-4399, 1998.
152. Holder N and Klein R. EPH receptors and ephrins: effectors of morphogenesis. Development 126: 2033-2044, 1999.
153. Hopkins AM, Walsh SV, Verkade P, Boquet P, and Nusrat A. Constitutive activation of Rho proteins by CNF-1 influences tight junction structure and epithelial barrier function. J Cell Sci 116: 725-742, 2003.
154. Hori M, Sato K, Miyamoto S, Ozaki H, and Karaki H. Different pathways of calcium sensitization activated by receptor agonists and phorbol esters in vascular smooth muscle. Br J Pharmacol 110: 1527-1531, 1993.
155. Huang AJ, Manning JE, Bandak TM, Ratau MC, Hanser KR, and Silverstein SC. Endothelial cell cytosolic free calcium regulates neutrophil migration across monolayers of endothelial cells. J Cell Biol 120: 1371-1380, 1993.
156. 20 phosphorylation. Mol Pharmacol 63: 1-8, 2003.
157. Ichikawa K, Ito M, and Hartshorne DJ. Phosphorylation of the large subunit of myosin phosphatase and inhibition of phosphatase activity. J Biol Chem 271: 4733-4740, 1996.
158. 2+ signalling in smooth muscle cells. In: Role of the Sarcoplasmic Reticulum in Smooth Muscle, edited by Goode DJC. West Sussex, UK: Wiley, 2002, p. 142-153.
159. Iizuka K, Shimizu Y, Tsukagoshi H, Yoshii A, Harada T, Dobashi K, Murozono T, Nakazawa T, and Mori M. Evaluation of Y-27632, a rho inhibitor, as a bronchodilator in guinea pigs. Eur J Pharmacol 406: 273-279, 2000.
160. 2+ sensitization through inhibition of myosin phosphatase in rabbit trachea. Br J Pharmacol 128: 925-933, 1999.
161. Ikebe M and Brozovich FV. Protein kinase C increases force and slows relaxation in smooth muscle: evidence for regulation of the myosin light chain phosphatase. Biochem Biophys Res Commun 225: 370-376, 1996.
162. Ishizaki T, Maekawa M, Fujisawa K, Okawa K, Iwamatsu A, Fujita A, Watanabe N, Saito Y, Kakizuka A, Morii N, and Narumiya S. The small GTP-binding protein Rho binds to and activates a 160 kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinase. EMBO J 15: 1885-1893, 1996.
163. ROCK, a Rho-associated coiled-coil forming protein kinase, works downstream of Rho and induces focal adhesions. FEBS Lett 404: 118-124, 1997.
164. Ishizaki T, Uehata M, Tamechika I, Keel J, Nonomura K, Maekawa M, and Narumiya S. Pharmacological properties of Y-27632, a specific inhibitor of
165. Ito K, Shimomura E, Iwanaga T, Shiraishi M, Shindo K, Nakamura J, Nagumo H, Seto M, Sasaki Y, and Takuwa Y. Essential role of rho kinase in the Ca(2+) sensitization of prostaglandin F(2alpha)-induced contraction of rabbit aortae. J Physiol 546: 823-836, 2003,
166. Ito M, Dabrowska R, Guerriero V Jr, and Hartshorne DJ. Identification in turkey gizzard of an acidic protein related to the C-terminal portion of smooth muscle myosin light chain kinase. J Biol Chem 264: 13971-13974, 1989.
167. 2+ sensitization and mobilization by MCh in tracheal smooth muscle. Am J Physiol Lung Cell Mol Physiol 280: L1218-L1224, 2001.
168. Itoh K, Yoshioka K, Akedo H, Uehata M, Ishizaki T, and Narumiya S. An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat Med 5: 221-225, 1999.
169. Jacinto A, Woolner S, and Martin P. Dynamic analysis of dorsal closure in Drosophila: from genetics to cell biology. Dev Cell 3: 9-19, 2002.
170. Jaggar JH, Porter VA, Lederer WJ, and Nelson MT. Calcium sparks in smooth muscle. Am J Physiol Cell Physiol 278: C235-C256, 2000.
171. Janssen LJ, Lu-Chao H, and Netherton S. Excitation-contraction coupling in pulmonary vascular smooth muscle involves tyrosine kinase and Rho kinase. Am J Physiol Lung Cell Mol Physiol 280: L666-L674, 2001.
172. 2+ sensitization of myosin light chain phosphorylation in smooth muscle. Biochem J 318: 469-475, 1996.
173. Jiang Y, Ma W, Wan Y, Kozasa T, Hattori S, and Huang XY. The G protein G alpha12 stimulates Bruton's tyrosine kinase and a rasGAP through a conserved PH/BM domain. Nature 395: 808-813, 1998.
174. Jo M, Thomas KS, Somlyo AV, Somlyo AP, and Gonias SL. Cooperativity between the Ras-ERK and Rho-Rho kinase pathways in urokinase-type plasminogen activator-stimulated cell migration. J Biol Chem 277: 12479-12485, 2002.
175. 2+ sensitivity in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 276: L35-L40, 1999.
176. Kahn RA. Fluoride is not an activator of the smaller (20-25 kDa) GTP-binding proteins. J Biol Chem 266: 15595-15597, 1991.
177. Kaibuchi K, Kuroda S, and Amano M. Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu Rev Biochem 68: 459-486, 1999.
178. Kaibuchi K, Kuroda S, Fukata M, and Nakagawa M. Regulation of cadherin-mediated cell-cell adhesion by the Rho family GTPases. Curr Opin Cell Biol 11: 591-596, 1999.
179. Kalsi JS, Cellek S, Muneer A, Kell PD, Ralph DJ, and Minhas S. Current oral treatments for erectile dysfunction. Expert Opin Pharmacother 3: 1613-1629, 2002.
180. Kamm KE and Stull JT. Dedicated myosin light chain kinases with diverse cellular functions. J Biol Chem 276: 4527-4530, 2001.
181. Kandabashi T, Shimokawa H, Miyata K, Kunihiro I, Kawano Y, Fukata Y, Higo T, Egashira K, Takahashi S, Kaibuchi K, and Takeshita A. Inhibition of myosin phosphatase by upregulated Rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1B. Circulation 101: 1319-1323, 2000.
182. Kaneko K, Satoh K, Masamune A, Satoh A, and Shimosegawa T. Expression of ROCK-1 in human pancreatic cancer: its down-regulation by morpholino oligo antisense can reduce the migration of pancreatic cancer cells in vitro. Pancreas 24: 251-257, 2002.
183. Karaki H, Ozaki H, Hori M, Mitsui-Saito M, Amano KI, Harada KI, Miyamoto S, Nakazawa H, Won KJ, and Sato K. Calcium movements, distribution, and functions in smooth muscle. Pharmacol Rev 49: 157-230, 1997.
184. Katoch SS, Su X, and Moreland RS. Ca(2+)- and protein kinase C-dependent stimulation of mitogen-activated protein kinase in detergent-skinned vascular smooth muscle. J Cell Physiol 179: 208-217, 1999.
185. Katoh H, Aoki J, Yamaguchi Y, Kitano Y, Ichikawa A, and Negishi M. Constitutively active Gα12, Gα13, and Gαq induce Rho-dependent neurite retraction through different signaling pathways. J Biol Chem 273: 28700-28707, 1998.
186. Katoh K, Kano Y, Amano M, Onishi H, Kaibuchi K, and Fujiwara K. Rho-kinase-mediated contraction of isolated stress fibers. J Cell Biol 153: 569-584, 2001.
187. 2+ desensitization of skinned rat artery. Eur J Pharmacol 323: 75-82, 1997.
188. 2+ sensitization in alpha-toxin-permeabilized vascular smooth muscle. Eur J Pharmacol 214: 39-44, 1992.
189. Kelley CA, Sellers JR, Gard DL, Bui D, Adelstein RS, and Baines IC. Xenopus nonmuscle myosin heavy chain isoforms have different subcellular localizations and enzymatic activities. J Cell Biol 134: 675-687, 1996.
190. Khatri JJ, Joyce KM, Brozovich FV, and Fisher SA. Role of myosin phosphatase isoforms in cGMP-mediated smooth muscle relaxation. J Biol Chem 276: 37250-37257, 2001.
191. Khromov AS, Somlyo AV, and Somlyo AP. MgADP promotes a catch-like state developed through force-calcium hysteresis in tonic smooth muscle. Biophys J 75: 1926-1934, 1998.
192. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, Feng J, Nakano T, Okawa K, Iwamatsu A, and Kaibuchi K. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273: 245-248, 1996.
193. Kimura K, Tsuji T, Takada Y, Miki T, and Narumiya S. Accumulation of GTP-bound RhoA during cytokinesis and a critical role of ECT2 in this accumulation. J Biol Chem 275: 17233-17236, 2000.
194. Kiosses WB, Daniels RH, Otey C, Bokoch GM, and Schwartz MA. A role for p21-activated kinase in endothelial cell migration. J Cell Biol 147: 831-844, 1999.
195. Kiss E, Muranyi A, Csortos C, Gergely P, Ito M, Hartshorne DJ, and Erdodi F. Integrin-linked kinase phosphorylates the myosin phosphatase target subunit at the inhibitory site in platelet cytoskeleton. Biochem J 365: 79-87, 2002.
196. Kitazawa T, Eto M, Woodsome TP, and Brautigan DL. Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility, J Biol Chem 275: 9897-9900, 2000.
197. 2+ sensitization in rabbit smooth muscle. J Physiol 546: 879-889, 2003.
198. 2+ sensitization of smooth muscle contraction through myosin light chain phosphorylation. J Biol Chem 266: 1708-1715, 1991.
199. 2+. J Biol Chem 264: 5339-5342, 1989.
200. Kitazawa T, Masuo M, and Somlyo AP. G protein-mediated inhibition of myosin light-chain phosphatase in vascular smooth muscle. Proc Natl Acad Sci USA 88: 9307-9310, 1991.
201. 2+ in smooth muscle. Biochem Biophys Res Commun 172: 1291-1297, 1990.
202. 2+ sensitization in Triton X-100-demembranated rabbit arterial smooth muscle. J Physiol 520: 139-152, 1999.
203. Klages B, Brandt U, Simon MI, Schultz G, and Offermanns S. Activation of G12/G13 results in shape change and Rho/Rho-kinase-mediated myosin light chain phosphorylation in mouse platelets. J Cell Biol 144: 745-754, 1999.
204. Klemke RL, Cai S, Giannini AL, Gallagher PJ, de Lanerolle P, and Cheresh DA. Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 137: 481-492, 1997.
205. 2+ sensitization. Am J Physiol Cell Physiol 260: C364-C370, 1991.
206. Kolega J. Cytoplasmic dynamics of myosin IIA and IIB: spatial "sorting" of isoforms in locomoting cells. J Cell Sci 111: 2085-2095, 1998.
207. Komalavilas P and Lincoln TM. Phosphorylation of the inositol 1,4,5-trisphosphate receptor. Cyclic GMP-dependent protein kinase mediates and cGMP dependent phosphorylation in the intact rat aorta. J Biol Chem 271: 21933-21938, 1996.
208. Komatsu S, Miyazaki K, Tuft RA, and Ikebe M. Translocation of telokin by cGMP signaling in smooth muscle cells. Am J Physiol Cell Physiol 283: C752-C761, 2002.
209. Kosako H, Yoshida T, Matsumura F, Ishizaki T, Narumiya S, and Inagaki M. Rho-kinase/ROCK is involved in cytokinesis through the phosphorylation of myosin light chain and not ezrin/radixin/moesin proteins at the cleavage furrow. Oncogene 19: 6059-6064, 2000.
210. Kotlikoff MI, Wang YX, Xin HB, and Ji G. Calcium release by ryanodine receptors in smooth muscle. In: Role of the Sarcoplasmic Reticulum in Smooth Muscle, edited by Derek J and Chadwick JAG. West Sussex, UK: Wiley, 2002, p. 108-124.
211. Kourlas PJ, Strout MP, Becknell B, Veronese ML, Croce CM, Theil KS, Krahe R, Ruutu T, Kinuutila S, Bloomfield CD, and Califiuri MA. Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia. Proc Natl Acad Sci USA 97: 2145-2150, 2000.
212. Koyama M, Ito M, Feng J, Seko T, Shiraki K, Takase K, Hartshorne DJ, and Nakano T. Phosphorylation of CPI-17, an inhibitory phosphoprotein of smooth muscle myosin phosphatase, by Rho-kinase. FEBS Lett 475: 197-200, 2000.
213. Kozasa T. Regulation of G protein-mediated signal transduction by RGS proteins. Life Sci 68: 2309-2317, 2001.
214. Kozasa T, Jiang X, Hart MJ, Sternweis PM, Singer WD, Gilman AG, Bollag G, and Sternweis PC. p115 RhoGEF, a GTPase activating protein for Galpha12 and Galpha13. Science 280: 2109-2111, 1998.
215. Krebs EG and Beavo JA. Phosphorylation-dephosphorylation of enzymes. Annu Rev Biochem 48: 923-959, 1979.
216. Krendel M, Zenke FT, and Bokoch GM. Nucleotide exchange factor GEF-H1 mediates cross-talk between microtubules and the actin cytoskeleton. Nat Cell Biol 4: 294-301, 2002.
217. Kudryashov DS, Chibalina MV, Birukov KG, Lukas TJ, Sellers JR, Van Eldik LJ, Watterson DM, and Shirinsky VP. Unique sequence of a high molecular weight myosin light chain kinase is involved in interaction with actin cytoskeleton. FEBS Lett 463: 67-71, 1999.
218. 12/Gα13 proteins in the murine nervous system. Eur J Neurosci 16: 2333-2341, 2002.
219. Kupittayanant S, Burdyga T, and Wray S. The effects of inhibiting Rho-associated kinase with Y-27632 on force and intracellular calcium in human myometrium. Pflügers Arch 443: 112-114, 2001.
220. 2+-independent smooth muscle contraction by alternative staurosporine-seusitive kinase. Eur J Pharmacol 376: 315-320, 1999.
221. Lazar V and Garcia JG. A single human myosin light chain kinase gene (MLCK; MYLK). Ge-nomics 57: 256-267, 1999.
222. Lee MW and Severson DL. Signal transduction in vascular smooth muscle: diacylglycerol second messengers and PKC action. Am J Physiol Cell Physiol 267: C659-C678, 1994.
223. Lesh RE, Emala CW, Lee HT, Zhu D, Panettieri RA, and Hirshman CA. Inhibition of geranylgeranylation blocks agonist-induced actin reorganization in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 281: L824-L831, 2001.
224. Leung T, Chen XQ, Manser E, and Lim L. The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol Cell Biol 16: 5313-5327, 1996.
225. Lim L, Manser E, Leung T, and Hall C. Regulation of phosphorylation pathways by p21 GTPases. The p21 Ras-related Rho sub-family and its role in phosphorylation signalling pathways. Eur J Biochem 242: 171-185, 1996.
226. Liu F, Verin AD, Wang P, Day R, Wersto RP, Chrest FJ, English DK, and Garcia JG. Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis. Involvement of G(ialpha2)-linked Rho kinase activity. Am J Respir Cell Mol Biol 24: 711-719, 2001.
227. Liu HW, Halayko AJ, Fernandes DJ, Harmon GS, McCauley JA, Kocieniewski P, McConville J, Fu Y, Forsythe SM, Kogut P, Bellam S, Dowell M, Churchill J, Lesso H, Kassiri K, Mitchell RW, Hershenson MB, Camoretti-Mercado B, and Solway J. The RhoA/Rho kinase pathway regulates nuclear localization of serum response factor. Am J Respir Cell Mol Biol 29: 39-47, 2003.
228. 2+ sensitization of rat smooth muscle. J Physiol 516: 825-834, 1999.
229. Longenecker K, Lewis ME, Chikumi H, Gutkind JS, and Derewenda ZS. Structure of the RGS-like domain from PDZ-RhoGEF: linking heterotrimeric G protein-coupled signaling to Rho GTPases. Structure 9: 559-569, 2001.
230. Longenecker K, Read P, Derewenda U, Dauter Z, Liu X, Garrard S, Walker L, Somlyo AV, Nakamoto RK, Somlyo AP, and Derewenda ZS. How RhoGDI binds Rho. Acta Crystallogr D Biol Crystallogr 55: 1503-1515, 1999.
231. Longenecker K, Read P, Lin SK, Somlyo AP, Nakamoto RK, and Derewenda ZS. Structure of a constitutively activated RhoA mutant (Q63L) at 1.55 A resolution. Acta Crystallogr D Biol Crystallogr 59: 876-880, 2003.
232. Lucius C, Arner A, Steusloff A, Troschka M, Hofmann F, Aktories K, and Pfitzer G. Clostridium difficile toxin B inhibits carbachol-induced force and myosin light chain phosphorylation in guinea-pig smooth muscle: role of Rho proteins. J Physiol 506: 83-93, 1998.
233. Lynch KR and MacDonald TL. Structure-activity relationships of lysophosphatidic acid analogs. Biochim Biophys Acta 1582: 289-294, 2002.
234. MacDonald JA, Borman MA, Muranyi A, Somlyo AV, Hartshorne DJ, and Haystead TA. Identification of the endogenous smooth muscle myosin phosphatase-associated kinase. Proc Natl Acad Sci USA 98: 2419-2424, 2001.
235. MacDonald JA, Eto M, Borman MA, Brautigan DL, and Haystead TAJ. Dual Ser and Thr phosphorylation of CPI-17, an inhibitor of myosin phosphatase, by MYPT-associated kinase. FEBS Lett 493: 91-94, 2001.
236. MacDonald JA, Walker LA, Nakamoto RK, Gorenne I, Somlyo AV, Somlyo AP, and Haystead TA. Phosphorylation of telokin by cyclic nucleotide kinases and the identification of in vivo phosphorylation sites in smooth muscle. FEBS Lett 479: 83-88, 2000.
237. Mack CP, Somlyo AV, Hautmann M, Somlyo AP, and Owens GK. Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization. J Biol Chem 276: 341-347, 2001.
238. Maekawa M, Ishizaki T, Boku S, Watanabe N, Fujita A, Iwamatsu A, Obinata T, Ohashi K, Mizuno K, and Narumiya S. Signaling from Rho to the actin cytoskeleton through protein Kinases ROCK and LIM-kinase. Science 285: 895-898, 1999.
239. 12-induced cytoskeletal responses. J Biol Chem 274: 26815-26821, 1999.
240. Majumdar M, Seasholtz TM, Goldstein D, de Lanerolle P, and Brown JH. Requirement for Rho-mediated myosin light chain phosphorylation in thrombin-stimulated cell rounding and its dissociation from mitogenesis. J Biol Chem 273: 10099-10106, 1998.
241. 13-G protein-coupled receptor complex and inhibits Rho activation. J Biol Chem 278: 124-130, 2003.
242. Masiero L, Lapidos KA, Ambudkar I, and Kohn EC. Regulation of the RhoA pathway in human endothelial cell spreading on type IV collagen: role of calcium influx. J Cell Sci 112: 3205-3213, 1999.
243. Matsui T, Amano M, Yamamoto T, Chihara K, Nakafuku M, Ito M, Nakano T, Okawa K, Iwamatsu A, and Kaibuchi K. Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J 15: 2208-2216, 1996.
244. Matsumura F, Totsukawa G, Yamakita Y, and Yamashiro S, Role of myosin light chain phosphorylation in the regulation of cytokinesis. Cell Struct Funct 26: 639-644, 2001.
245. Matthew JD, Khromov AS, McDuffie MJ, Somlyo AV, Somlyo AP, Taniguchi S, and Takahashi K. Contractile properties and proteins of smooth muscles of a calponin knockout mouse. J Physiol 529: 811-824, 2000.
246. McConnell BK, Moravec CS, and Bond M. Troponin I phosphorylation and myofilament calcium sensitivity during decompensated cardiac hypertrophy. Am J Physiol Heart Circ Physiol 274: H385-H396, 1998.
247. McFawn PK, Shen L, Vincent SG, Mak A, Van Eyk JE, and Fisher JT. Calcium-independent contraction and sensitization of airway smooth muscle by p21-activated protein kinase. Am J Physiol Lung Cell Mol Physiol 284: L863-L870, 2003.
248. 2+-insensitive contraction and paxillin tyrosine phosphorylation in smooth muscle. Am J Physiol Cell Physiol 279: C308-C318, 2000.
249. Miller JR, Silver PJ, and Stull JT. The role of myosin light chain kinase phosphorylation in beta-adrenergic relaxation of tracheal smooth muscle. Mol Pharmacol 24: 235-242, 1983.
250. Mills TM, Chitaley K, Wingard CJ, Lewis RW, and Webb RC. Effect of Rho-kinase inhibition on vasoconstriction in the penile circulation. J Appl Physiol 91: 1269-1273, 2001.
251. Mita M, Yanagihara H, Hishinuma S, Saito M, and Walsh MP. Membrane depolarization-induced contraction of rat caudal arterial smooth muscle involves Rho-associated kinase. Biochem J 364: 431-440, 2002.
252. Miura M, Iwanaga T, Ito KM, Seto M, Sasaki Y, and Ito K. The role of myosin light chain kinase-dependent phosphorylation of myosin light chain in phorbol ester-induced contraction of rabbit aorta. Pflügers Arch 434: 685-693, 1997.
253. Miyazaki K, Yano T, Schmidt DJ, Tokui T, Shibata M, Lifshitz LM, Kimura S, Tuft RA, and Ikebe M. Rho-dependent agonist-induced spatio-temporal change in myosin phosphorylation in smooth muscle cells. J Biol Chem 277: 725-734, 2002.
254. Moon S and Zheng Y. Tho GTPase-activating proteins in cell regulation. Trends Cell Biol 13: 13-22, 2003.
255. Moorhead G, Johnson D, Morrice N, and Cohen P. The major myosin phosphatase in skeletal muscle is a complex between the beta-isoform of protein phosphatase 1 and the MYPT2 gene product. FEBS Lett 438: 141-144, 1998.
256. Morrison DL, Sanghera JS, Stewart J, Sutherland C, Walsh MP, and Pelech SL. Phosphorylation and activation of smooth muscle myosin light chain kinase by MAP kinase and cyclin-dependent kinase-1. Biochem Cell Biol 74: 549-557, 1996.
257. Mukai H. The structure and function of PKN, a protein kinase having a catalytic domain homologous to that of PKC. J Biochem 133: 17-27, 2003.
258. Mukai Y, Shimokawa H, Matoba T, Kandabashi T, Satoh S, Hiroki J, Kaibuchi K, and Takeshita A. Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension. FASEB J 15: 1062-1064, 2001.
259. Murakami H, Iwashita T, Asai N, Iwata Y, Narumiya S, and Takahashi M. Rho-dependent and -independent tyrosine phosphorylation of focal adhesion kinase, paxillin and p130Cas mediated by Ret kinase. Oncogene 18: 1975-1982, 1999.
260. Murata-Hori M, Fukuta Y, Ueda K, Iwasaki T, and Hosoya H. HeLa ZIP kinase induces diphosphorylation of myosin II regulatory light chain and reorganization of actin filaments in nonmuscle cells. Oncogene 20: 8175-8183, 2001.
261. Murata-Hori M, Suizu F, Iwasaki T, Kikuchi A, and Hosoya H. ZIP kinase identified as a novel myosin regulatory light chain kinase in HeLa cells. FEBS Lett 451: 81-84, 1999.
262. Murthy KS, Zhou H, Grider JR, Brautigan DL, Eto M, and Makhlouf GM. Differential signaling by muscarinic receptors in smooth muscle: m2-mediated inactivation of MLCK via Gi3, Cdc42/Rac1, and PAK1, and m3-mediated MLC20 phosphorylation via Rho kinase/MYPT1 and PKC/CPI-17 pathways. Biochem J. In press.
263. Murthy KS, Zhou H, Grider JR, and Makhlouf GM. Inhibition of sustained smooth muscle contraction by PKA and PKG preferentially mediated by phosphorylation of RhoA. Am J Physiol Gastronintest Liver Physiol 284: G1006-G1016, 2003.
264. Nagumo H, Sasaki Y, Ono Y, Okamoto H, Seto M, and Takuwa Y. Rho kinase inhibitor HA-1077 prevents Rho-mediated myosin phosphatase inhibition in smooth muscle cells. Am J Physiol Cell Physiol 278: C57-C65, 2000.
265. Nakabayashi H, Sellers JR, and Huang KP. Catalytic fragment of protein kinase C exhibits altered substrate specificity toward smooth muscle myosin light chain. FEBS Lett 294: 144-148, 1991.
266. Nakajima M, Hayashi K, Katayama K, Amano Y, Egi Y, Uehata M, Goto N, and Kondo T. Wf-536 prevents tumor metastasis by inhibiting both tumor motility and angiogenic actions. Eur J Pharmacol 459: 113-120, 2003.
267. Nakamura K, Nishimura J, Hirano K, Ibayashi S, Fujishima M, and Kanaide H. Hydroxyfasudil, an active metabolite of fasudil hydrochloride, relaxes the rabbit basilar artery by disinhibition of myosin light chain phosphatase. J Cereb Blood Flow Metab 21: 876-885, 2001.
268. Nakamura M, Ichikawa K, Ito M, Yamamori B, Okinaka T, Isaka N, Yoshida Y, Fujita S, and Nakano T. Effects of the phosphorylation of myosin phosphatase by cyclic GMP-dependent protein kinase. Cell Signal 11: 671-676, 1999.
269. 2+ sensitization of coronary artery contractions mediated by a sphingosylphosphorylcholine-Rho-kinase pathway. Circ Res 91: 953-960, 2002.
270. Neufeld G, Cohen T, Shraga N, Lange T, Kessler O, and Herzog Y. The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis. Trends Cardiovasc Med 12: 13-19, 2002.
271. Nguyen DH, Catling AD, Webb DJ, Sankovic M, Walker LA, Somlyo AV, Weber MJ, and Gonias SL. Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner. J Cell Biol 146: 149-164, 1999.
272. Niggli V. Microtubule-disruption-induced and chemotactic-peptide-induced migration of human neutrophils: implications for differential sets of signaling pathways. J Cell Sci 116: 813-822, 2003.
273. Niiro N and Ikebe M. Zipper-interacting protein kinase induces Ca(2+)-free smooth muscle contraction via myosin light chain phosphorylation. J Biol Chem 276: 29567-29574, 2001.
274. Niiro N, Koga Y, and Ikebe M. Agonist-induced changes in the phosphorylation of the myosin-binding subunit of myosin light chain phosphatase and CPI17, two regulatory factors of myosin light chain phosphatase, in smooth muscle. Biochem J 369: 117-128, 2003.
275. Nishikawa M, de Lanerolle P, Lincoln TM, and Adelstein RS. Phosphorylation of mammalian myosin light chain kinases by the catalytic subunit of cyclic AMP-dependent protein kinase and by cyclic GMP-dependent protein kinase. J Biol Chem 259: 8429-8436, 1984.
276. Nishimura J and van Breemen C. Direct regulation of smooth muscle contractile elements by second messengers. Biochem Biophys Res Commun 163: 929-935, 1989.
277. 2+ sensitivity in rabbit smooth muscle. J Physiol 487: 283-289, 1995.
278. 2+ sensitization in porcine coronary artery. Circ Res 88: 1283-1290, 2001.
279. Nobes CD and Hall A. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81: 53-62, 1995.
280. Nobes CD, Hawkins P, Stephens L, and Hall A. Activation of the small GTP-binding proteins rho and rac by growth factor receptors. J Cell Sci 108: 225-233, 1995.
281. Nobes CD, Lauritzen I, Mattei MG, Paris S, Hall A, and Chardin P. A new member of the Rho family, Rnd1, promotes disassembly of actin filament structures and loss of cell adhesion. J Cell Biol 141: 187-197, 1998.
282. Noland TA Jr, Guo X, Raynor RL, Jideama NM, Averyhart-Fullard V, Solaro RJ, and Kuo JF. Cardiac troponin I mutants. Phosphorylation by protein kinases C and A and regulation of Ca(2+)-stimulated MgATPase of reconstituted actomyosin S-1. J Biol Chem 270: 25445-25454, 1995.
283. Ogita H, Kunimoto S, Kamioka Y, Sawa H, Masuda M, and Mochizuki N. EphA4-mediated Rho activation via Vsm-RhoGEF expressed specifically in vascular smooth muscle cells. Circ Res. In press.
284. Ogut O and Brozovich FV. Determinants of the contractile properties in the embryonic chicken gizzard and aorta. Am J Physiol Cell Physiol 279: C1722-C1732, 2000.
285. Ohashi K, Nagata K, Maekawa M, Ishizaki T, Narumiya S, and Mizuno K. Rho-associated kinase ROCK activates LIM-kinase 1 by phosphorylation at threonine 508 within the activation loop. J Biol Chem 275: 3577-3582, 2000.
286. Oinuma I, Katoh H, Harada A, and Negishi M. Direct interaction of Rnd1 with Plexin-B1 regulates PDZ-RhoGEF-mediated Rho activation by Plexin-B1 and induces cell contraction in COS-7 cells. J Biol Chem. In press.
287. Olofsson B. Rho guanine dissociation inhibitors: pivotal molecules in cellular signalling. Cell Signal 11: 545-554, 1999.
288. Olson MF, Sterpetti P, Nagata K, Toksoz D, and Hall A. Distinct roles for DH and PH domains in the Lbc oncogene. Oncogene 15: 2827-2831, 1997.
289. Owens GK. Role of contractile agonists in growth regulation of vascular smooth muscle cells. Adv Exp Med Biol 308: 71-79, 1991.
290. Owens GK. Determinants of angiotensin II-induced hypertrophy versus hyperplasia in vascular smooth muscle. Drug Dev Res 29: 83-87, 1993.
291. Paik JH, Chae S, Lee MJ, Thangada S, and Hla T. Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and Rho-dependent activation of alpha vbeta3- and beta1-containing integrins. J Biol Chem 276: 11830-11837, 2001.
292. Parris JRM, Cobban HJ, Littlejohn AF, MacEwan DJ, and Nixon GF. Tumour necrosis factor-alpha activates a calcium sensitization pathway in guinea-pig bronchial smooth muscle. J Physiol 518: 561-569, 1999.
293. , Patel BN and Van Vactor DL. Axon guidance: the cytoplasmic tail. Curr Opin Cell Biol 14: 221-229, 2002.
294. Paul BZ, Daniel JL, and Kunapuli SP. Platelet shape change is mediated by both calcium-dependent and -independent signaling pathways. Role of p160 Rho-associated coiled-coil-containing protein kinase in platelet shape change. J Biol Chem 274: 28293-28300, 1999.
295. Peck J, Douglas G IV, Wu CH, and Burbelo PD. Human RhoGAP domain-containing proteins: structure, function and evolutionary relationships. FEBS Lett 528: 27-34, 2002.
296. Perrot V, Vazquez-Prado J, and Gutkind JS. Plexin B regulates Rho through the guanine nucleotide exchange factors leukemia-associated Rho GEF (LARG) and PDZ-RhoGEF, J Biol Chem 277: 42115-43120, 2002.
297. Pfeifer A, Klatt P, Massberg S, Ny L, Sausbier M, Hirneiss C, Wang GX, Korth M, Aszodi A, Andersson KE, Krombach F, Mayerhofer A, Ruth P, Fassler R, and Hofmann F. Defective smooth muscle regulation in cGMP kinase I-deficient mice. EMBO J 17: 3045-3051, 1998.
298. Pfitzer G, Hofmann F, DiSalvo J, and Ruegg JC. cGMP and cAMP inhibit tension development in skinned coronary arteries. Pflügers Arch 401: 277-280, 1984.
299. Pfitzer G, Sonntag-Bensch D, and Brkic-Koric D. Thiophosphorylation-induced Ca(2+) sensitization of guinea-pig ileum contractility is not mediated by Rho-associated kinase. J Physiol 533: 651-664, 2001.
300. Piekny AJ, Wissmann A, and Mains PE. Embryonic morphogenesis in Caenorhabditis elegans integrates the activity of LET-502 Rho-binding kinase, MEL-11 myosin phosphatase, DAF-2 insulin receptor and FEM-2 PP2c phosphatase. Genetics 156: 1671-1689, 2000.
301. Qiu RG, Chen J, McCormick F, and Symons M. A role for Rho in Ras transformation. Proc Natl Acad Sci USA 92: 11781-11785, 1995.
302. Read PW, Liu X, Longenecker K, Dipierro CG, Walker LA, Somlyo AV, Somlyo AP, and Nakamoto RK. Human RhoA/RhoGDI complex expressed in yeast: GTP exchange is sufficient for translocation of RhoA to liposomes. Protein Sci 9: 376-386, 2000.
303. Redwood CS, Marston SB, and Gusev NB. The functional effects of mutations Thr673→Asp and Ser702→Asp at the Pro-directed kinase phosphorylation sites in the C-terminus of chicken gizzard caldesmon. FEBS Lett 327: 85-89, 1993.
304. Rees RW, Ralph DJ, Royle M, Moncada S, and Cellek S. Y-27632, an inhibitor of Rho-kinase, antagonizes noradrenergic contractions in the rabbit and human penile corpus cavernosum. Br J Pharmacol 133: 455-458, 2001.
305. Ren XD, Kiosses WB, and Schwartz MA. Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. EMBO J 18: 578-585, 1999.
306. Ren Y, Li R, Zheng Y, and Busch H. Cloning and characterization of GEF-H1, a microtubule-associated guanine nucleotide exchange factor for Rac and Rho GTPases. J Biol Chem 273: 34954-34960, 1998.
307. Reyes-Reyes M, Mora N, Zentella A, and Rosales C. Phosphatidylinositol 3-kinase mediates integrin-dependent NF-κB and MAPK activation through separate signaling pathways. J Cell Sci 114: 1579-1598, 2001.
308. Richards CT, Ogut O, and Brozovich FV. Agonist-induced force enhancement: the role of isoforms and phosphorylation of the myosin-targeting subunit of myosin light chain phosphatase. J Biol Chem 277: 4422-4427, 2002.
309. Ridley AJ and Hall A. Signal transduction pathways regulating Rho-mediated stress fibre formation: requirement for a tyrosine kinase. EMBO J 13: 2600-2610, 1994.
310. Rittinger K, Walker PA, Eccleston JF, Smerdon SJ, and Gamblin Structure at 1 SJ. 65 A of RhoA and its GTPase-activating protein in complex with a transition-state analogue. Nature 389: 758-762, 1997.
311. Robbe K, Otto-Bruc A, Chardin P, and Antonny B. Dissociation of GDP dissociation inhibitor and membrane translocation are required for efficient activation of rac by the dbl homology-pleckstrin homology region of tiam. J Biol Chem 278: 4756-4762, 2003.
312. Robertson TP, Dipp M, Ward JP, Aaronson PI, and Evans AM. Inhibition of sustained hypoxic vasoconstriction by Y-27632 in isolated intrapulmonary arteries and perfused lung of the rat. Br J Pharmacol 131: 5-9, 2000.
313. Rokolya A, Barany M, and Barany K. Modification of myosin light chain phosphorylation in sustained arterial muscle contraction by phorbol dibutyrate. Biochim Biophys Acta 1057: 276-280, 1991.
314. Rossman KL, Cheng L, Mahon GM, Rojas RJ, Snyder JT, Whitehead IP, and Sondek J. Multifunctional roles for the PH domain of Dbs in regulating Rho GTPase activation. J Biol Chem 278: 18393-18400, 2003.
315. Rozengurt E and Rodriguez-Fernandez JL. Tyrosine phosphorylation in the action of neuropeptides and growth factors. Essays Biochem 32: 73-86, 1997.
316. 2+ sensitization by myosin phosphatase inhibition. J Physiol 520: 3, 1999.
317. Sachdev P, Zeng L, and Wang LH. Distinct role of phosphatidylinositol 3-kinase and Rho family GTPases in Vav3-induced cell transformation, cell motility, and morphological changes. J Biol Chem 277: 17638-17648, 2002.
318. Sah VP, Seasholtz TM, Sagi SA, and Brown JH. The role of Rho in G protein-coupled receptor signal transduction. Annu Rev Pharmacol Toxicol 40: 459-489, 2000.
319. Sahai E, Ishizaki T, Narumiya S, and Treisman R. Transformation mediated by RhoA requires activity of ROCK kinases. Curr Biol 9: 136-145, 1999.
320. Sahai E and Marshall CJ. Rho-GRPases and cancer. Nature Rev 2: 133-142, 2002.
321. Saito H, Minamiya Y, Saito S, and Ogawa J. Endothelial Rho and Rho kinase regulate neutrophil migration via endothelial myosin light chain phosphorylation. J Leukoc Biol 72: 829-836, 2002.
322. Sakurada S, Okamoto H, Takuwa N, Sugimoto N, and Takuwa Y. Rho activation in excitatory agonist-stimulated vascular smooth muscle. Am J Physiol Cell Physiol 281: C571-C578, 2001.
323. Sander EE, ten Klooster JP, van Delft S, van der Kammen RA, and Collard JG. Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behavior. J Cell Biol 147: 1009-1022, 1999.
324. Sanders LC, Matsumura F, Bokoch GM, and de Lanerolle P. Inhibition of myosin light chain kinase by p21-activated kinase. Science 283: 2083-2085, 1999.
325. Sasaki Y, Suzuki M, and Hidaka H. The novel and specific Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinoline)-sulfonyl] -homopiperazine as a probing molecule for Rho-kinase-involved pathway. Pharmacol Ther 93: 225-232, 2002.
326. Sato M, Tani E, Fujikawa H, and Kaibuchi K. Involvement of Rho-kinase-mediated phosphorylation of myosin light chain in enhancement of
327. Satoh S, Kreutz R, Wilm C, Ganten D, and Pfitzer G. Augmented agonist-induced Ca(2+)-sensitization of coronary artery contraction in genetically hypertensive rats. Evidence for altered signal transduction in the coronary smooth muscle cells. J Clin Invest 94: 1397-1403, 1994.
328. 2+ sensitization of contraction in vascular smooth muscle. J Biol Chem 275: 21722-21729, 2000.
329. Sauzeau V, Le Jeune H, Cario-Toumaniantz C, Vaillant N, Gadeau AP, Desgranges C, Scalbert E, Chardin P, Pacaud P, and Loirand G. P2Y(1), P2Y(2), P2Y(4), and P2Y(6) receptors are coupled to Rho and Rho kinase activation in vascular myocytes. Am J Physiol Heart Circ Physiol 278: H1751-H1761, 2000.
330. Sauzeau V, Rolli-Derkinderen M, Marionneau C, Loirand G, and Pacaud P. RhoA expression is controlled by nitric oxide through cGMP-dependent protein kinase activation. J Biol Chem 278: 9472-9480, 2003.
331. Sawada N, Itoh H, Ueyama K, Yamashita J, Doi K, Chun T, Inoue M, Masatsugu K, Saito T, Fukunaga Y, Sakaguchi S, Arai H, Ohno N, Komeda M, and Nakao K. Inhibition of Rho-associated kinase results in suppression of neointimal formation of balloon-injured arteries. Circulation 101: 2030-2033, 2000.
332. Sawada N, Itoh H, Yamashita J, Doi K, Inoue M, Masatsugu K, Fukunaga Y, Sakaguchi S, Sone M, Yamahara K, Yurugi T, and Nakao K. cGMP-dependent protein kinase phosphorylates and inactivates RhoA. Biochem Biophys Res Commun 280: 798-805, 2001.
333. Schmidt A and Hall A. Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. Genes Dev 16: 1587-1609, 2002.
334. 20 phosphorylation." Am J Physiol Cell Physiol 284: C596-C598, 2003.
335. Seasholtz TM, Majumdar M, and Brown JH. Rho as a mediator of G-protein-coupled receptor signaling. Mol Pharmacol 55: 949-956, 1999.
336. Seasholtz TM, Majumdar M, Kaplan DD, and Brown JH. Rho and Rho kinase mediate thrombin-stimulated vascular smooth muscle cell DNA synthesis and migration. Circ Res 84: 1186-1193, 1999.
337. Kip1 expression in the vasculature of hypertensive rats. Circ Res 89: 488-495, 2001.
338. Seko T, Ito M, Kureishi Y, Okamoto R, Moriki N, Onishi K, Isaka N, Hartshorne DJ, and Nakano T. Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle. Circ Res 92: 411-418, 2003.
339. Sellers JR. Regulation of cytoplasmic and smooth muscle myosin. Curr Opin Cell Biol 3: 98-104, 1991.
340. Sells MA, Boyd JT, and Chernoff J. p21-activated kinase 1 (Pak1) regulates cell motility in mammalian fibroblasts. J Cell Biol 145: 837-849, 1999.
341. Shao F, Vacratsis PO, Bao Z, Bowers KE, Fierke CA, and Dixon JE. Biochemical characterization of the Yersinia YopT protease: cleavage site and recognition elements in Rho GTPases. Proc Natl Acad Sci USA 100: 904-909, 2003.
342. Shimizu H, Ito M, Miyahara M, Ichikawa K, Okubo S, Konishi T, Naka M, Tanaka T, Hirano K, and Hartshorne DJ. Characterization of the myosin-binding subunit of smooth muscle myosin phosphatase. J Biol Chem 269: 30407-30411, 1994.
343. Shimokawa H, Morishige K, Miyata K, Kandabashi T, Eto Y, Ikegaki I, Asano T, Kaibuchi K, and Takeshita A. Long-term inhibition of Rho-kinase induces a regression of arteriosclerotic coronary lesions in a porcine model in vivo. Cardiovasc Res 51: 169-177, 2001.
344. Shimokawa H, Seto M, Katsumata N, Amano M, Kozai T, Yamawaki T, Kuwata K, Kandabashi T, Egashira K, Ikegaki I, Asano T, Kaibuchi K, and Takeshita A. Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. Cardiovasc Res 43: 1029-1039, 1999.
345. Shin D, Garcia-Cardena G, Hayashi SI, Gerety S, Asahara T, Stavrakis G, Isner J, Folkman J, Gimbrone MA, and Anderson DJ. Expression of EphrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization. Dev Biol 230: 139-150, 2001.
346. Shin HM, Je HD, Gallant C, Tao TC, Hartshorne DJ, Ito M, and Morgan KG. Differential association and localization of myosin phosphatase subunits during agonist-induced signal transduction in smooth muscle. Circ Res 90: 546-553, 2002.
347. Shirazi A, Iizuka K, Fadden P, Mosse C, Somlyo AP, Somlyo AV, and Haystead TA. Purification and characterization of the mammalian myosin light chain phosphatase holoenzyme. The differential effects of the holoenzyme and its subunits on smooth muscle. J Biol Chem 269: 31598-31606, 1994.
348. Skinner JA and Saltiel AR. Cloning and identification of MYPT3: a prenylatable myosin targetting subunit of protein phosphatase 1. Biochem J 356: 257-267, 2001.
349. Smith L, Parizi-Robinson M, Zhu MS, Zhi G, Fukui R, Kamm KE, and Stull JT. Properties of long myosin light chain kinase binding to F-actin in vitro and in vivo. J Biol Chem 277: 35597-35604, 2002.
350. Snyder JT, Rossman KL, Baumeister MA, Pruitt WM, Siderovski DP, Der CJ, Lemmon MA, and Sondek J. Quantitative analysis of the effect of phophoinositide interactions on the function of Dbl family proteins. J Biol Chem 276: 45868-45875, 2001.
351. Soga N, Namba N, McAllister S, Cornelius L, Teitelbaum SL, Dowdy SF, Kawamura J, and Hruska KA. Rho family GTPases regulate VEGF-stimulated endothelial cell motility. Exp Cell Res 269: 73-87, 2001.
352. 2+-sensitivity and of the time course of concentration in smooth muscle: a major role of protein phosphatases? Adv Prot Phosphatases 5: 181-195, 1989.
353. Somlyo AP and Somlyo AV. Signal transduction and regulation in smooth muscle. Nature 372: 231-236, 1994.
354. Somlyo AP and Somlyo AV. Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol 522: 177-185, 2000.
355. Somlyo AP and Somlyo AV. The sarcoplasmic reticulum: then and now. Novartis Found Symp 246: 258-286, 2002.
356. 2+ sensitization. Circ Res 91: 83-84, 2002.
357. Somlyo AV, Bradshaw D, Ramos S, Murphy C, Myers CE, and Somlyo AP. Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells. Biochem Biophys Res Commun 269: 652-659, 2000.
358. Somlyo AV, Phelps C, Dipierro C, Eto M, Read P, Barrett M, Gibson JJ, Burnitz MC, Myers C, and Somlyo AP. Rho kinase and matrix metalloproteinase inhibitors cooperate to inhibit angiogenesis and growth of human prostate cancer xenotransplants. FASEB J 17: 223-234, 2003.
359. Somlyo AV and Somlyo AP. Electromechanical and pharmaco-mechanical coupling in vascular smooth muscle. J Pharmacol Exp Ther 159: 129-145, 1968.
360. Sorg I, Goehring UM, Aktories K, and Schmidt G. Recombinant Yersinia YopT leads to uncoupling of RhoA-effector interaction. Infect Immun 69: 7535-7543, 2001.
361. Spiegel S and Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 4: 397-407, 2003.
362. 2+ sensitivity in smooth muscle by genistein and protein tyrosine phosphorylation. Arch Biochem Biophys 320: 236-242, 1995.
363. Stull JT, Hsu LC, Tansey MG, and Kamm KE. Myosin light chain kinase phosphorylation in tracheal smooth muscle. J Biol Chem 265: 16683-16690, 1990.
364. Stull JT, Lin PJ, Krueger JK, Trewhella J, and Zhi G. Myosin light chain kinase: functional domains and structural motifs. Acta Physiol Scand 164: 471-482, 1998.
365. Sugai M, Hashimoto K, Kikuchi A, Inoue S, Okumura H, Matsumoto K, Goto Y, Ohgai H, Moriishi K, and Syuto B. Epidermal cell differentiation inhibitor ADP-ribosylates small GTP-binding proteins and induces hyperplasia of epidermis. J Biol Chem 267: 2600-2604, 1992.
366. Sumi T, Matsumoto K, and Nakamura T. Specific activation of LIM kinase 2 via phosphorylation of threonine 505 by ROCK, a Rho-dependent protein kinase. J Biol Chem 276: 670-676, 2001.
367. Surks HK, Mochizuki N, Kasai Y, Georgescu SP, Tang KM, Ito M, Lincoln TM, and Mendelsohn ME. Regulation of myosin phosphatase by a specific interaction with cGMP-dependent protein kinase Ialpha. Science 286: 1583-1587, 1999.
368. Suzuki N, Nakamura S, Mano H, and Kozasa T. Gα12 activates Rho GTPase through tyrosine-phosphorylated leukemia-associated RhoGEF. Proc Natl Acad Sci USA 100: 733-738, 2003.
369. 2+ sensitization of myosin phosphorylation and force in guinea-pig ileum. J Physiol 522: 33-49, 2000.
370. Swiercz JM, Kuner R, Behrens J, and Offermanns S. Plexin-B1 directly interacts with PDZ-RhoGEF/LARG to regulate RhoA and growth cone morphology. Neuron 35: 51-63, 2002.
371. Taggart MJ, Lee YH, and Morgan KG. Cellular redistribution of PKCα, rhoA, and ROKα following smooth muscle agonist stimulation. Exp Cell Res 251: 92-101, 1999.
372. Tahara M, Morishige K, Sawada K, Ikebuchi Y, Kawagishi R, Tasaka K, and Murata Y. RhoA/Rho-kinase cascade is involved in oxytocin-induced rat uterine contraction. Endocrinology 143: 920-929, 2002.
373. Takizawa N, Koga Y, and Ikebe M. Phosphorylation of CPI17 and myosin binding subunit of type 1 protein phosphatase by p21-activated kinase. Biochem Biophys Res Commun 297: 773-778, 2002.
374. Takizawa N, Niiro N, and Ikebe M. Dephosphorylation of the two regulatory components of myosin phosphatase, MBS and CPI17. FEBS Lett 515: 127-132, 2002.
375. Tamagnone L, Artigiani S, Chen H, He Z, Ming GI, Song HJ, Chedotal A, Winberg ML, Goodman CS, Poo MM, Tessler-Lavigne M, and Comoglio PM. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 99: 71-80, 1999.
376. Tamas P, Solti Z, Bauer P, Illes A, Sipeki S, Bauer A, Farago A, Downward J, and Buday L. Mechanism of epidermal growth factor regulation of Vav2, a guanine nucleotide exchange factor for Rac. J Biol Chem 278: 5163-5171, 2003.
377. Tan I, Ng CH, Lim L, and Leung T. Phosphorylation of a novel myosin binding subunit of protein phosphatase 1 reveals a conserved mechanism in the regulation of actin cytoskeleton. J Biol Chem 276: 21209-21216, 2001.
378. Tang DC, Kubota Y, Kamm KE, and Stull JT. GTP gamma S-induced phosphorylation of myosin light chain kinase in smooth muscle. FEBS Lett 331: 272-275, 1993.
379. 2+ sensitivity of light chain phosphorylation within smooth muscle cells. J Biol Chem 269: 9912-9920, 1994.
380. Tatsumoto T, Xie X, Blumenthal R, Okamoto I, and Miki T. Human ECT2 is an exchange factor for Rho GTPases, phosphorylated in G2/M phases, and involved in cytokinesis. J Cell Biol 147: 921-927, 1999.
381. Taya S, Inagaki N, Sengiku H, Makino H, Iwamatsu A, Urakawa I, Nagao K, Kataoka S, and Kaibuchi K. Direct interaction of insulin-like growth factor-1 receptor with leukemia-associated RhoGEF. J Cell Biol 155: 809-820, 2001.
382. 2+-sensitization of vascular smooth muscle contraction: possible involvement of Rho-kinase, FEBS Lett 482: 85-90, 2000.
383. Tomomasa T, Takahashi A, Kaneko H, Watanabe T, Tabata M, Kato M, and Morikawa A. Y-27632 inhibits gastric motility in conscious rats. Life Sci 66: PL29-PL34, 2000.
384. Toth A, Kiss E, Gergely P, Walsh MP, Hartshorne DJ, and Erdodi F. Phosphorylation of MYPT1 by protein kinase C attenuates interaction with PP1 catalytic subunit and the 20 kDa light chain of myosin. FEBS Lett 484: 113-117, 2000.
385. Totsukawa G, Yamakita Y, Yamashiro S, Hartshorne DJ, Sasaki Y, and Matsumura F. Distinct roles of ROCK (Rho-kinase) and MLCK in spatial regulation of MLC phosphorylation for assembly of stress fibers and focal adhesions in 3T3 fibroblasts. J Cell Biol 150: 797-806, 2000.
386. Totsukawa G, Yamakita Y, Yamashiro S, Hosoya H, Hartshorne DJ, and Matsumura F. Activation of myosin phosphatase targeting subunit by mitosis-specific phosphorylation. J Cell Biol 144: 735-744, 1999.
387. Trinkle-Mulcahy L, Ichikawa K, Hartshorne DJ, Siegman MJ, and Butler TM. Thiophosphorylation of the 130-kDa subunit is associated with a decreased activity of myosin light chain phosphatase in alpha-toxin-permeabilized smooth muscle. J Biol Chem 270: 18191-18194, 1995.
388. Ueda K, Murata-Hori M, Tatsuka M, and Hosoya H. Rho-kinase contributes to diphosphorylation of myosin II regulatory light chain in non-muscle cells. Oncogene 21: 5852-5860, 2002.
389. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, and Narumiya S. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389: 990-994, 1997.
390. VanBavel E, van der Meulen ET, and Spaan JA. Role of Rho-associated protein kinase in tone and calcium sensitivity of cannulated rat mesenteric small arteries. Exp Physiol 86: 585-592, 2001.
391. 2+-independent contraction of smooth muscle. J Biol Chem 273: 23433-23439, 1998.
392. Van Horck FPG, Ahmadian MR, Haeusler LC, Moolenaar WH, and Kranenburg O. Characterization of p190RhoGEF, a RhoA-specific guanine nucleotide exchange factor that interacts with microtubules. J Biol Chem 276: 4948-4956, 2001.
393. Van Nieuw Amerongen GP, Draijer R, Vermeer MA, and van Hinsbergh VW. Transient and prolonged increase in endothelial permeability induced by histamine and thrombin: role of protein kinases, calcium, and RhoA. Circ Res 83: 1115-1123, 1998.
394. Van Nieuw Amerongen GP, van Delft S, Vermeer MA, Collard JG, and van Hinsbergh VW. Activation of RhoA by thrombin in endothelial hyperpermeability: role of Rho kinase and protein tyrosine kinases. Circ Res 87: 335-340, 2000.
395. Van Nieuw Amerongen GP, Vermeer MA, and van Hinsbergh VW. Role of RhoA and Rho kinase in lysophosphatidic acid-induced endothelial barrier dysfunction. Arterioscler Thromb Vasc Biol 20: E127-E133, 2000.
396. Van Riper DA, Weaver BA, Stull JT, and Rembold CM. Myosin light chain kinase phosphorylation in swine carotid artery contraction and relaxation. Am J Physiol Heart Circ Physiol 268: H2466-H2475, 1995.
397. Velasco G, Armstrong C, Morrice N, Frame S, and Cohen P. Phosphorylation of the regulatory subunit of smooth muscle protein phosphatase 1M at Thr850 induces its dissociation from myosin. FEBS Lett 527: 101-104, 2002.
398. Verin AD, Lazar V, Torry RJ, Labarrere CA, Patterson CE, and Garcia JG. Expression of a novel high molecular-weight myosin light chain kinase in endothelium. Am J Respir Cell Mol Biol 19: 758-766, 1998.
399. Vogt S, Grosse R, Schultz G, and Offermanns S. Receptor dependent RhoA activation in G12/G12 deficient cells: genetic evidence for an involvement of Gq/G11. J Biol Chem. In press.
400. Vouret-Craviari V, Boquet P, Pouyssegur J, and Van Obberghen-Schilling E. Regulation of the actin cytoskeleton by thrombin in human endothelial cells: role of Rho proteins in endothelial barrier function. Mol Biol Cell 9: 2639-2653, 1998.
401. Vouret-Craviari V, Bourcier C, Boulter E, and van Obberghen-Schilling E. Distinct signals via Rho GTPases and Src drive shape changes by thrombin and sphingosine-1-phosphate in endothelial cells. J Cell Sci 115: 2475-2484, 2002.
402. Wahl S, Barth H, Ciossek T, Aktories I, and Mueller B. Ephrin-A5 induces collapse of growth cones by activating Rho and Rho kinase. J Cell Biol 149: 263-270, 2000.
403. Walker LA, Gailly P, Jensen PE, Somlyo AV, and Somlyo AP. The unimportance of being (protein kinase C) epsilon. FASEB J 12: 813-821, 1998.
404. 2+-desensitizing effect in smooth muscle. J Biol Chem 276: 24519-24524, 2001.
405. Walsh MP, Horowitz A, Clement-Chomienne O, Andrea JE, Allen BG, and Morgan KG. Protein kinase C mediation of Ca(2+)-independent contractions of vascular smooth muscle. Biochem Cell Biol 74: 485-502, 1996.
406. Walsh MP, Kargacin GJ, Kendrick-Jones J, and Lincoln TM. Intracellular mechanisms involved in the regulation of vascular smooth muscle tone. Can J Physiol Pharmacol 73: 565-573, 1995.
407. Wang F, Nobes CD, Hall A, and Spiegel S. Sphingosine 1-phosphate stimulates Rho-mediates tyrosine phosphorylation of focal adhesion kinase and paxillin in Swiss 3T3 fibroblasts. Biochem J 324: 481-488, 1997.
408. 2+ sensitization in erectile function. J Biol Chem 277: 30614-30621, 2002.
409. Wang HU, Chen ZF, and Anderson DJ. Molecule distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93: 741-753, 1998.
410. Wang Z, Jin N, Ganguli S, Swartz DR, Li L, and Rhoades RA. Rho-kinase activation is involved in hypoxia-induced pulmonary vasoconstriction. Am J Respir Cell Mol Biol 25: 628-635, 2001.
411. Webb DJ, Parsons JT, and Horwitz AF. Adhesion assembly, disassembly and turnover in migrating cells: over and over and over again. Nat Cell Biol 4: E97-E100, 2002.
412. 2+-independent phosphorylation of myosin in rat caudal artery and chicken gizzard myofilaments. J Physiol 516: 805-824, 1999.
413. Wei Y, Zhang Y, Derewenda U, Liu X, Minor W, Nakamoto RK, Somlyo AV, Somlyo AP, and Derewenda ZS. Crystal structure of RhoA-GDP and its functional implications. Nat Struct Biol 4: 699-703, 1997,
414. Weisbrod RM, Griswold MC, Yaghoubi M, Komalavilas P, Lincoln TM, and Cohen RA. Evidence that additional mechanisms to cyclic GMP mediate the decrease in intracellular calcium and relaxation of rabbit aortic smooth muscle to nitric oxide. Br J Pharmacol 125: 1695-1707, 1998.
415. Wells CD, Gutowski S, Bollag G, and Sternweis PC. Identification of potential mechanisms for regulation of p115 RhoGEF through analysis of endogenous and mutant forms of the exchange factor. J Biol Chem 276: 28897-28905, 2001.
416. 13 and Rho exchange factors. J Biol Chem 277: 1174-1181, 2002.
417. Wettschureck N and Offermanns S. Rho/Rho-kinase mediated signaling in physiology and pathophysiology. J Mol Med 80: 629-638, 2002.
418. Wirth A, Schroeter M, Kock-Hauser C, Manser E, Chalovich JM, De Lanerolle P, and Pfitzer G. Inhibition of contraction and myosin light chain phosphorylation in guinea-pig smooth muscle by p21-activated kinase 1. J Physiol 549: 489-500, 2003.
419. Wissmann A, Ingles J, and Mains PE. The Caenorhabditis elegans mel-11 myosin phosphatase regulatory subunit affects tissue contraction in the somatic gonad and the embryonic epidermis and genetically interacts with the Rac signaling pathway. Dev Biol 209: 111-127, 1999.
420. Wissmann A, Ingles J, McGhee JD, and Mains PE. Caenorhabditis elegans LET-502 is related to Rho-binding kinases and human myotonic dystrophy kinase and interacts genetically with a homolog of the regulatory subunit of smooth muscle myosin phosphatase to affect cell shape. Genes Dev 11: 409-422, 1997.
421. Wojciak-Stothard B, Potempa S, Eichholtz T, and Ridley AJ. Rho and Rac but not Cdc42 regulate endothelial cell permeability. J Cell Sci 114: 1343-1355, 2001.
422. Woodsome TP, Eto M, Everett A, Brautigan DL, and Kitazawa T. Expression of CPI-17 and myosin phosphatase correlates with Ca(2+) sensitivity of protein kinase C-induced contraction in rabbit smooth muscle. J Physiol 535: 553-564, 2001.
423. Worthylake RA, Lemoine S, Watson JM, and Burridge K. RhoA is required for monocyte tail retraction during transendothelial migration. J Cell Biol 154: 147-160, 2001.
424. Wu X, Haystead TA, Nakamoto RK, Somlyo AV, and Somlyo AP. Acceleration of myosin light chain dephosphorylation and relaxation of smooth muscle by telokin. Synergism with cyclic nucleotide-activated kinase. J Biol Chem 273: 11362-11369, 1998.
425. Wu X, Somlyo AV, and Somlyo AP. Cyclic GMP-dependent stimulation reverses G-protein-coupled inhibition of smooth muscle myosin light chain phosphate. Biochem Biophys Res Commun 220: 658-663, 1996.
426. Wysolmerski RB and Lagunoff D. Involvement of myosin light-chain kinase in endothelial cell retraction. Proc Natl Acad Sci USA 87: 16-20, 1990.
427. Xia C, Bao Z, Yue C, Sanborn BM, and Liu M. Phosphorylation and regulation of G-protein-activated phospholipase C-beta 3 by cGMP-dependent protein kinases. J Biol Chem 276: 19770-19777, 2001.
428. Yamakawa T, Tanaka S, Numaguchi K, Yamakawa Y, Motley ED, Ichihara S, and Inagami T. Involvement of Rho-kinase in angiotensin II-induced hypertrophy of rat vascular smooth muscle cells. Hypertension 35: 313-318, 2000.
429. Yamashiro S, Totsukawa G, Yamakita Y, Sasaki Y, Madaule P, Ishizaki T, Narumiya S, and Matsumura F. Citron kinase, a Rho-independent kinase, induces di-phosphorylation of regulatory light chain of myosin II. Mol Biol Cell 14: 1745-1756, 2003.
430. Yamboliev IA, Hedges JC, Mutnick JL, Adam LP, and Gerthoffer WT. Evidence for modulation of smooth muscle force by the p38 MAP kinase/HSP27 pathway. Am J Physiol Heart Circ Physiol 278: H1899-H1907, 2000.
431. Yancopoulos GD, Klagsbrun M, and Folkman J. Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border, Cell 93: 661-664, 1998.
432. 2+ sensitization in stretch-induced myogenic tone. Cardiovasc Res 53: 431-438, 2002.
433. 2+ sensitization. Am J Respir Cell Mol Biol 20: 1190-1200, 1999.
434. Yoshimura H, Jones KA, Perkins WJ, Kai T, and Warner DO. Calcium sensitization produced by G protein activation in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 281: L631-L638, 2001.
435. 2+ elevation and contraction in iris sphincter smooth muscle. Eur J Pharmacol 360: 185-193, 1998.
436. Zeng Q, Lagunoff D, Masaracchia R, Goeckeler Z, Cote G, and Wysolmerski R. Endothelial cell retraction is induced by PAK2 monophosphorylation of myosin II. J Cell Sci 113: 471-482, 2000.
437. Zhang D, Wang Z, Jin N, Li L, Rhoades RA, Yancey KW, and Swartz DR. Microtubule disruption modulates the Rho-kinase pathway in vascular smooth muscle. J Muscle Res Cell Motil 22: 193-200, 2001.
438. Zheng Y, Glaven JA, Wu WJ, and Cerione RA. Phosphatidylinositol 4,5-bisphosphate provides an alternative to guanine nucleotide exchange factors by stimulating the dissociation of GDP from Cdc42Hs. J Biol Chem 271: 23815-23819, 1996.
439. 2+ sensitivity of porcine renal artery. J Physiol 516: 55-65, 1999.
440. Zimmermann B, Somlyo AV, Ellis-Davies GC, Kaplan JH, and Somlyo AP. Kinetics of prephosphorylation reactions and myosin light chain phosphorylation in smooth muscle. Flash photolysis studies with caged calcium and caged ATP. J Biol Chem 270: 23966-23974, 1995.
441. Zohn IM, Campbell SL, Khosravi-Far R, Rossman KL, and Der CJ. Rho family proteins and ras transformation: the RHOad less traveled gets congested. Oncogene 17: 1415-1438, 1998.
442. Zumbihl R, Aepfelbacher M, Andor A, Jacobi CA, Ruckdeschel K, Rouot B, and Heesemann J. The cytotoxin YopT of Yersinia enterocolitica induces modification and cellular redistribution of the small GTP-binding protein RhoA. J Biol Chem 274: 29289-29293, 1999.